TNFRSF10A and cancer: In cancer, EMT selectively inhibits apoptosis signaling via the death receptor 4 TNF-related apoptosis-inducing ligand-receptor 1 (TRAIL-R1) and/or death receptor 5 TRAIL-R2 [69].